Browse by:
Research & Development

Study: Hartford needs a bailout or bankruptcy

Patricia Daddona |

Hartford is the “most broken” of Connecticut's four challenged cities and will likely need a state bailout or bankruptcy protection to deal with its fiscal crisis, according to a new...

Larson seeks funds for concrete study

Eric Bedner | Journal Inquirer |

Sen. Timothy D. Larson, D-East Hartford, is seeking funding for a Connecticut Academy of Science and Engineering study to determine the number of homes affected by crumbling concrete foundations and...

Survey: U.S. investors, analysts optimistic in 1Q

Patricia Daddona |

Business sentiment and growth expectations look promising under the incoming presidential administration, according to a survey conducted by Hartford-based investor research firm Corbin Perception.

Meriden vaccine maker progresses with Zika vaccine

Patricia Daddona |

The Meriden-based maker of the Flublok influenza vaccine announced Thursday its lead Zika vaccine candidate performed well in pre-clinical studies.

East Hartford firm, UConn collaborating on hydrogen vehicle sensor

Patricia Daddona |

East Hartford's Sustainable Innovations Inc. (SI) and UConn's Center for Clean Energy Engineering are developing a hydrogen fuel quality sensor to help ensure reliability of hydrogen vehicles.

Alexion antibody wins FDA orphan drug status

Patricia Daddona |

The U.S. Food and Drug Administration has designated as an orphan drug an Alexion Pharmaceuticals' long-acting antibody that may be used to treat a rare blood disorder.

Study: CT, NY, NJ experiencing outbound migration

Patricia Daddona |

Connecticut is one of several states experiencing an exodus of residents over the past year, according to the latest United Van Lines' 40th Annual National Movers Study.

DCP: Deteriorating foundations must show evidence of mineral

Patricia Daddona |

The mineral pyrrhotite, thought to be a contributor to a rash of deteriorating foundations across the state, must be present to make the concrete deteriorate, although the exact amount has not yet...

Hep C treatment trial using Achillion drug attracts $15M

Patricia Daddona |

New Haven-based Achillion Pharmaceuticals, Inc. said Wednesday it received a $15 million milestone payment for research related to a drug trial for chronic hepatitis C.

Marijuana study greenlighted at St. Francis hospital

Patricia Daddona |

St. Francis Hospital and Medical Center will be the first in Connecticut to conduct medical marijuana research under a new program authorized by the legislature.

Copyright 2017 New England Business Media